COMMUNITY-ACQUIRED PNEUMONIA OLEH KLEBSIELLA PNEUMONIAE DI RSUP DR. M. DJAMIL PADANG TAHUN 2024: GAMBARAN MORTALITAS TINGGI DAN TANTANGAN KLINIS

Ruhsyahadati Ruhsyahadati; Nana Liana; Rahma Triyana; Dian Puspita; Muhammad Rizki Saputra; Roland Helmizar; Rifkind Malik; Aulia Akbar

doi:10.59003/nhj.v5i8.1859

Authors

Ruhsyahadati Ruhsyahadati Universitas Baiturrahmah
Nana Liana Universitas Baiturrahmah
Rahma Triyana Universitas Baiturrahmah
Dian Puspita Universitas Baiturrahmah
Muhammad Rizki Saputra Universitas Baiturrahmah
Roland Helmizar Universitas Baiturrahmah
Rifkind Malik Universitas Baiturrahmah
Aulia Akbar Universitas Baiturrahmah

DOI:

https://doi.org/10.59003/nhj.v5i8.1859

Keywords:

community-acquired pneumonia, Klebsiella pneumoniae, mortality, antibiotic resistance, antibiogram, empirical therapy

Abstract

Community-acquired pneumonia (CAP) caused by Klebsiella pneumoniae is frequently associated with severe clinical courses and high mortality, particularly among elderly patients and those with comorbidities. The increasing rate of antimicrobial resistance has further limited the effectiveness of standard empirical therapy. This was a retrospective descriptive observational study using secondary data from medical records of hospitalized CAP patients at Dr. M. Djamil General Hospital, Padang, from January 2022 to December 2023. Subjects were adults (≥18 years) diagnosed with CAP and with positive cultures for K. pneumoniae. Variables included demographic characteristics, length of hospital stay, clinical outcomes, and antibiotic susceptibility patterns. Data were analyzed using univariate descriptive analysis. A total of 50 patients were included, predominantly male (58%) and aged over 65 years (40%). The most frequent comorbidities were hypertension (60%) and diabetes mellitus (36%). The mean length of hospital stay was 14 days. Mortality was high, reaching 56%. Antibiotic susceptibility testing showed the highest sensitivity to meropenem (96%) and amikacin (92%), while commonly used first-line agents such as ceftriaxone, ampicillin–sulbactam, and ciprofloxacin demonstrated low sensitivity (<15%). CAP due to Klebsiella pneumoniae at Dr. M. Djamil General Hospital is associated with very high mortality and widespread resistance to first-line antibiotics. Empirical therapy should be guided by local antibiogram data and supported by strong antimicrobial stewardship programs.

Downloads

Download data is not yet available.

References

Yu X, Suo L, Sun X, Sun T, Wang L, Qi X, et al. Analysis of clinical characteristics and mortality risk factors in patients with community-acquired pneumonia caused by Klebsiella pneumoniae. Diagnostic Microbiol Infect Dis. 2025;111:116660. Available from: https://doi.org/10.1016/j.diagmicrobio.2024.116660

Souza A De, Monteiro S, Silva MDO, Galvão VS, Bomfim AP, Araújo LG De, et al. High proportions of multidrug- resistant Klebsiella pneumoniae isolates in community-acquired infections , Brazil. Sci Rep. 2025;15.

Itani R, Khojah HMJ, Raychouni H, Kibrit R, Shuhaiber P, Dib C, et al. Management practices and mortality predictors among Klebsiella pneumoniae infections across Lebanese hospitals : a multicenter retrospective study. BMC Infect Dis. 2025;25:620.

Narlis, Nasrul E, Efrida. Pola Kuman dan Uji Kepekaan pada Pasien Community Acquired Pneumonia di RSUP Dr . M . Djamil Padang Tahun 2016. J Kesehat Andalas. 2019;8:553–7.

Ayu D, Aisaka P, Arikandini R, Nyoman N, Budayanti S. Klebsiella pneumoniae in pneumonia patients at Ngoerah Hospital from 2020 to 2022. J Clin Microbiol Infect Dis. 2025;5:12–6.

Juan C, Fang S, Chou C, Tsai T, Lin Y. Clinical characteristics of patients with pneumonia caused by Klebsiella pneumoniae in Taiwan and prevalence of antimicrobial-resistant and hypervirulent strains : a retrospective study. Antimicrob Resist Infect Control. 2020;9:1–8.

Hyun H, Young J, Id S, Yoon JG, Seong H, Noh JY, et al. Risk factor-based analysis of community- acquired pneumonia , healthcare-associated pneumonia and hospital-acquired pneumonia : Microbiological distribution , antibiotic resistance , and clinical outcomes. PLoS One. 2022;17:1–15.

Warlem N, Abdullah D, Morawati S, Yasa F, Yudistira R, Baiturrahmah U. Profil Pneumonia pada Pasien Rawat Inap Paru RSUP M. Djamil. Nusant Hasana J. 2024;3:14–22.

Chen Y-C, Tsai I, Lai C-H, Lin K-H, Hsu Y-C. Risk Factors and Outcomes of Community-Acquired Carbapenem-Resistant Klebsiella pneumoniae Infection in Elderly Patients. Antibiotics. 2024;13:282.

Singh G, Loho T, Yulianti M, Aditianingsih D, Zakiyah LF, Masse SF, et al. Factors associated with antibiotic resistance and survival analysis of severe pneumonia patients infected with Klebsiella pneumoniae , Acinetobacter baumannii , and Pseudomonas aeruginosa : A retrospective cohort study in Jakarta , Indonesia. Sage Open Med. 2024;12:1–10.